pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Oncaspar
drug
save

pegaspargase

Marketedupdated 3mo ago
by Servier Pharmaceuticals LLC
Approved
community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying pegaspargase

  • phase2SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphomaactive not recruitingn=240
  • phase2A Phase 2 Study of Ruxolitinib With Chemotherapy in Children With Acute Lymphoblastic Leukemiacompletedn=171
  • phase3Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphomanot yet recruitingn=150
  • phase3Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescentsactive not recruitingn=560
  • phase1Ruxolitinib and Chemotherapy in Adolescents and Young Adults With Ph-like Acute Lymphoblastic Leukemiarecruitingn=15
  • phase3Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphomaactive not recruitingn=790
  • phase2Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclaxactive not recruitingn=35
  • phase3A French Protocol for the Treatment of Acute Lymphoblastic Leukemia (ALL) in Children and Adolescentsactive not recruitingn=2,044
more trials →

News(0)

no news has mentioned this drug yet

brand
Oncaspar
generic
pegaspargase
indication
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
phase
marketed
Data sources
ClinicalTrials.gov
last refreshed 14m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?